Chronic Lung Diseases Completed Phase 1 Trials for Moxifloxacin (DB00218)

Also known as: Lung Disease / Lung Diseases / Chronic Lung Disease / Calcification of lung / Disorder lung / Lung disorder / Lung disorder (NOS) / Lung disorder NOS / Pulmonary disorder / Disorder pulmonary / Pneumopathy

IndicationStatusPhase
DBCOND0044039 (Chronic Lung Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01107054A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy VolunteersTreatment
NCT01222442To Evaluate the Effect of AZD3199 on the Electrical Activity in the HeartBasic Science